Relay Therapeutics, Inc.RLAYNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank71
3Y CAGR+13.2%
5Y CAGR-12.2%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
+13.2%/yr
Annual compound
5Y CAGR
-12.2%/yr
Recent acceleration
Percentile
P71
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20252.56+238.3%
20240.76-57.8%
20231.79+1.7%
20221.76-45.8%
20213.25-33.6%
20204.90+689.6%
2019-0.83-5.9%
2018-0.79-